30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Artivion Inc (AORT)

Track

In the last 90 days, Artivion Inc. has seen insider selling activity totaling $1,821,506.98 from 2 transactions. Notably, Andrew M. Green, an Officer, made proposed sales on June 11, 2026, amounting to $910,752.99. This activity occurred against a backdrop of a significant stock price decline over the past 90 days.
Stock chart
Ticker: AORT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GREEN ANDREW M
SVP, Regulatory and Quality
4 sales — total 400,000 USD
Planned sale 11 Jun 2026
Value US$1,402,595.61 | Price 98.25 | Shares 65,287
Planned sale 11 Jun 2026
Value US$4,601,464.40 | Price 348.48 | Shares 25,052
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 20.70 | Shares 1,000
Proposed sale 11 Jun 2026
Value US$100,000.00 | Price 20.70 | Shares 1,000
Sale 4 Mar 2026
Value US$181,650.31 | Price 307.69 | Shares 42,106
Proposed sale 4 Mar 2026
Value US$340,556.00 | Price 38.00 | Shares 8,962
Sale 3 Mar 2026
Value US$34,035.82 | Price 37.78 | Shares 901
Proposed sale 3 Mar 2026
Value US$34,035.82 | Price 37.78 | Shares 901
Sale 3 Mar 2026
Value US$145,171.63 | Price 37.78 | Shares 3,843
Proposed sale 3 Mar 2026
Value US$145,171.63 | Price 37.78 | Shares 3,843
Sale 3 Mar 2026
Value US$81,179.76 | Price 37.78 | Shares 2,149
Proposed sale 3 Mar 2026
Value US$81,179.76 | Price 37.78 | Shares 2,149
Sale 3 Mar 2026
Value US$172,747.82 | Price 37.78 | Shares 4,573
Proposed sale 3 Mar 2026
Value US$172,747.82 | Price 37.78 | Shares 4,573
Sale 3 Mar 2026
Value US$238,590.69 | Price 37.78 | Shares 6,316
Proposed sale 3 Mar 2026
Value US$238,590.69 | Price 37.78 | Shares 6,316
Sale 3 Mar 2026
Value US$675,692.16 | Price 37.78 | Shares 17,887
Proposed sale 3 Mar 2026
Value US$675,692.16 | Price 37.78 | Shares 17,887
Sale 2 Mar 2026
Value US$24,373.96 | Price 38.02 | Shares 641
Proposed sale 2 Mar 2026
Value US$24,373.96 | Price 38.02 | Shares 641
Sale 2 Mar 2026
Value US$57,531.67 | Price 38.02 | Shares 1,513
Proposed sale 2 Mar 2026
Value US$57,531.67 | Price 38.02 | Shares 1,513
Sale 2 Mar 2026
Value US$566,989.28 | Price 38.02 | Shares 14,911
Proposed sale 2 Mar 2026
Value US$566,989.28 | Price 38.02 | Shares 14,911
Sale 2 Mar 2026
Value US$83,008.36 | Price 38.02 | Shares 2,183
Proposed sale 2 Mar 2026
Value US$83,008.36 | Price 38.02 | Shares 2,183
Sale 2 Mar 2026
Value US$196,892.93 | Price 38.02 | Shares 5,178
Proposed sale 2 Mar 2026
Value US$196,892.93 | Price 38.02 | Shares 5,178
Sale 2 Mar 2026
Value US$105,861.32 | Price 38.02 | Shares 2,784
Proposed sale 2 Mar 2026
Value US$105,861.32 | Price 38.02 | Shares 2,784
Sale 24 Feb 2026
Value US$29,625.19 | Price 35.69 | Shares 830
Proposed sale 24 Feb 2026
Value US$29,625.11 | Price 35.69 | Shares 830
Sale 24 Feb 2026
Value US$59,535.92 | Price 35.69 | Shares 1,668
Proposed sale 24 Feb 2026
Value US$59,535.76 | Price 35.69 | Shares 1,668
Sale 24 Feb 2026
Value US$44,937.49 | Price 35.69 | Shares 1,259
Proposed sale 24 Feb 2026
Value US$44,937.36 | Price 35.69 | Shares 1,259
Sale 24 Feb 2026
Value US$497,417.65 | Price 35.69 | Shares 13,936
Proposed sale 24 Feb 2026
Value US$497,416.25 | Price 35.69 | Shares 13,936
Sale 24 Feb 2026
Value US$160,083.10 | Price 35.69 | Shares 4,485
Proposed sale 24 Feb 2026
Value US$160,082.66 | Price 35.69 | Shares 4,485
Sale 24 Feb 2026
Value US$74,062.97 | Price 35.69 | Shares 2,075
Proposed sale 24 Feb 2026
Value US$74,062.77 | Price 35.69 | Shares 2,075
Sale 23 Feb 2026
Value US$65,064.83 | Price 37.59 | Shares 1,731
Proposed sale 23 Feb 2026
Value US$65,063.96 | Price 37.59 | Shares 1,731
Sale 23 Feb 2026
Value US$115,733.45 | Price 37.59 | Shares 3,079
Proposed sale 23 Feb 2026
Value US$115,731.92 | Price 37.59 | Shares 3,079
Sale 23 Feb 2026
Value US$91,075.72 | Price 37.59 | Shares 2,423
Proposed sale 23 Feb 2026
Value US$91,074.51 | Price 37.59 | Shares 2,423
Sale 23 Feb 2026
Value US$787,919.66 | Price 37.59 | Shares 20,962
Proposed sale 23 Feb 2026
Value US$787,909.17 | Price 37.59 | Shares 20,962
Sale 23 Feb 2026
Value US$187,225.83 | Price 37.59 | Shares 4,981
Proposed sale 23 Feb 2026
Value US$187,223.34 | Price 37.59 | Shares 4,981
Sale 23 Feb 2026
Value US$141,819.52 | Price 37.59 | Shares 3,773
Proposed sale 23 Feb 2026
Value US$141,817.64 | Price 37.59 | Shares 3,773
Proposed sale 15 Dec 2025
Value US$225,553.67 | Price 45.11 | Shares 5,000
Sale 15 Dec 2025
Value US$225,550.00 | Price 45.11 | Shares 5,000
Sale 8 Dec 2025
Value US$203,083.67 | Price 44.42 | Shares 4,572
Proposed sale 8 Dec 2025
Value US$203,081.38 | Price 44.42 | Shares 4,572
Planned sale 3 Dec 2025
Value US$1,405,699.58 | Price 45.46 | Shares 30,921
Proposed sale 3 Dec 2025
Value US$1,405,695.03 | Price 45.46 | Shares 30,921
Sale 3 Dec 2025
Value US$238,595.10 | Price 45.30 | Shares 5,267
Sale 3 Dec 2025
Value US$92,774.40 | Price 45.30 | Shares 2,048
Proposed sale 3 Dec 2025
Value US$331,390.71 | Price 45.30 | Shares 7,315
Planned sale 2 Dec 2025
Value US$1,408,729.84 | Price 45.56 | Shares 30,921
Proposed sale 2 Dec 2025
Value US$1,430,714.67 | Price 46.27 | Shares 30,921
Sale 21 Nov 2025
Value US$379,537.65 | Price 45.35 | Shares 8,370
Sale 21 Nov 2025
Value US$840,041.55 | Price 44.91 | Shares 18,705
Sale 21 Nov 2025
Value US$259,152.39 | Price 45.35 | Shares 5,715
Sale 21 Nov 2025
Value US$655,188.53 | Price 44.92 | Shares 14,586
Proposed sale 21 Nov 2025
Value US$2,133,936.47 | Price 45.04 | Shares 47,376
Sale 20 Nov 2025
Value US$59,996.69 | Price 44.28 | Shares 1,355
Sale 20 Nov 2025
Value US$90,092.39 | Price 44.32 | Shares 2,033
Sale 20 Nov 2025
Value US$524,736.32 | Price 44.14 | Shares 11,888
Proposed sale 20 Nov 2025
Value US$674,833.49 | Price 44.18 | Shares 15,276
Sale 18 Nov 2025
Value US$189,411.60 | Price 45.10 | Shares 4,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-15 2026-06-11 PlS Planned sale
1.5
GREEN ANDREW M

SVP, Regulatory and Quality

Officer
65,287 -27.2%
98.25
US$1,402,596 		65,287 -27.2% 98.25 US$1,402,596
2026-06-15 2026-06-11 PlS Planned sale
1.5
GREEN ANDREW M

SVP, Regulatory and Quality

Officer
25,052 -36.0%
348.48
US$4,601,464 		25,052 -36.0% 348.48 US$4,601,464
2026-06-11 2026-06-11 PrS Proposed sale
1.5
GREEN ANDREW M

Officer

Officer
20,315
257.37
US$1,520,319 		20,315 257.37 US$1,520,319
2026-06-11 2026-06-11 PrS Proposed sale
1.5
GREEN ANDREW M

Officer

Officer
1,000
20.70
US$100,000 		1,000 20.70 US$100,000
2026-03-04 2026-03-04 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
8,962 -4.6%
38.00
US$340,556 		8,962 -4.6% 38.00 US$340,556
2026-03-04 2026-03-04 PrS Proposed sale
3.5
JEAN F HOLLOWAY

Officer

Officer
8,962
38.00
US$340,556 		8,962 38.00 US$340,556
2026-03-04 2026-03-03 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
901 -0.6%
37.78
US$34,036 		901 -0.6% 37.78 US$34,036
2026-03-04 2026-03-03 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
3,843 -1.9%
37.78
US$145,172 		3,843 -1.9% 37.78 US$145,172
2026-03-04 2026-03-03 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
2,149 -3.5%
37.78
US$81,180 		2,149 -3.5% 37.78 US$81,180
2026-03-04 2026-03-03 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
4,573 -1.9%
37.78
US$172,748 		4,573 -1.9% 37.78 US$172,748
2026-03-04 2026-03-03 S Sale
2.8
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
6,316 -2.9%
37.78
US$238,591 		6,316 -2.9% 37.78 US$238,591
2026-03-04 2026-03-03 S Sale
3.5
Mackin James P

President & CEO

Officer
17,887 -1.9%
37.78
US$675,692 		17,887 -1.9% 37.78 US$675,692
2026-03-03 2026-03-03 PrS Proposed sale
3.5
Holloway Jean F

Officer

Officer
3,843
37.78
US$145,172 		3,843 37.78 US$145,172
2026-03-03 2026-03-03 PrS Proposed sale
2.8
Berry Lance A

Officer

Officer
6,316
37.78
US$238,591 		6,316 37.78 US$238,591
2026-03-03 2026-03-03 PrS Proposed sale
3.4
Davis John E

Officer

Officer
4,573
37.78
US$172,748 		4,573 37.78 US$172,748
2026-03-03 2026-03-03 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
2,149
37.78
US$81,180 		2,149 37.78 US$81,180
2026-03-03 2026-03-03 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
17,887
37.78
US$675,692 		17,887 37.78 US$675,692
2026-03-03 2026-03-03 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
901
37.78
US$34,036 		901 37.78 US$34,036
2026-03-03 2026-03-02 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
641 -0.5%
38.02
US$24,374 		641 -0.5% 38.02 US$24,374
2026-03-03 2026-03-02 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
1,513 -3.6%
38.02
US$57,532 		1,513 -3.6% 38.02 US$57,532
2026-03-03 2026-03-02 S Sale
3.5
Mackin James P

President & CEO

Officer
14,911 -1.7%
38.02
US$566,989 		14,911 -1.7% 38.02 US$566,989
2026-03-03 2026-03-02 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
2,183 -1.3%
38.02
US$83,008 		2,183 -1.3% 38.02 US$83,008
2026-03-03 2026-03-02 S Sale
2.8
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
5,178 -2.9%
38.02
US$196,893 		5,178 -2.9% 38.02 US$196,893
2026-03-03 2026-03-02 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
2,784 -1.3%
38.02
US$105,861 		2,784 -1.3% 38.02 US$105,861
2026-03-02 2026-03-02 PrS Proposed sale
3.5
Holloway Jean F

Officer

Officer
2,183
38.02
US$83,008 		2,183 38.02 US$83,008
2026-03-02 2026-03-02 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
14,911
38.02
US$566,989 		14,911 38.02 US$566,989
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Davis John E

Officer

Officer
2,784
38.02
US$105,861 		2,784 38.02 US$105,861
2026-03-02 2026-03-02 PrS Proposed sale
2.8
Berry Lance A

Officer

Officer
5,178
38.02
US$196,893 		5,178 38.02 US$196,893
2026-03-02 2026-03-02 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
641
38.02
US$24,374 		641 38.02 US$24,374
2026-03-02 2026-03-02 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
1,513
38.02
US$57,532 		1,513 38.02 US$57,532
2026-02-25 2026-02-24 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
830 -0.6%
35.69
US$29,625 		830 -0.6% 35.69 US$29,625
2026-02-25 2026-02-24 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
1,668 -1.1%
35.69
US$59,536 		1,668 -1.1% 35.69 US$59,536
2026-02-25 2026-02-24 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
1,259 -2.9%
35.69
US$44,937 		1,259 -2.9% 35.69 US$44,937
2026-02-25 2026-02-24 S Sale
3.5
Mackin James P

President & CEO

Officer
13,936 -1.8%
35.69
US$497,418 		13,936 -1.8% 35.69 US$497,418
2026-02-25 2026-02-24 S Sale
2.8
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
4,485 -3.0%
35.69
US$160,083 		4,485 -3.0% 35.69 US$160,083
2026-02-25 2026-02-24 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
2,075 -1.1%
35.69
US$74,063 		2,075 -1.1% 35.69 US$74,063
2026-02-24 2026-02-24 PrS Proposed sale
3.4
Davis John E

Officer

Officer
2,075
35.69
US$74,063 		2,075 35.69 US$74,063
2026-02-24 2026-02-24 PrS Proposed sale
2.8
Berry Lance A

Officer

Officer
4,485
35.69
US$160,083 		4,485 35.69 US$160,083
2026-02-24 2026-02-24 PrS Proposed sale
3.5
Holloway Jean F

Officer

Officer
1,668
35.69
US$59,536 		1,668 35.69 US$59,536
2026-02-24 2026-02-24 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
13,936
35.69
US$497,416 		13,936 35.69 US$497,416
2026-02-24 2026-02-24 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
1,259
35.69
US$44,937 		1,259 35.69 US$44,937
2026-02-24 2026-02-24 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
830
35.69
US$29,625 		830 35.69 US$29,625
2026-02-25 2026-02-23 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
1,731 -1.3%
37.59
US$65,065 		1,731 -1.3% 37.59 US$65,065
2026-02-25 2026-02-23 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
3,079 -2.0%
37.59
US$115,733 		3,079 -2.0% 37.59 US$115,733
2026-02-25 2026-02-23 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
2,423 -5.3%
37.59
US$91,076 		2,423 -5.3% 37.59 US$91,076
2026-02-25 2026-02-23 S Sale
3.5
Mackin James P

President & CEO

Officer
20,962 -2.6%
37.59
US$787,920 		20,962 -2.6% 37.59 US$787,920
2026-02-25 2026-02-23 S Sale
2.8
Berry Lance A

EVP, COO, CFO & Treasurer

Officer
4,981 -3.2%
37.59
US$187,226 		4,981 -3.2% 37.59 US$187,226
2026-02-25 2026-02-23 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
3,773 -1.9%
37.59
US$141,820 		3,773 -1.9% 37.59 US$141,820
2026-02-23 2026-02-23 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
1,731
37.59
US$65,064 		1,731 37.59 US$65,064
2026-02-23 2026-02-23 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
20,962
37.59
US$787,909 		20,962 37.59 US$787,909
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Davis John E

Officer

Officer
3,773
37.59
US$141,818 		3,773 37.59 US$141,818
2026-02-23 2026-02-23 PrS Proposed sale
3.5
Holloway Jean F

Officer

Officer
3,079
37.59
US$115,732 		3,079 37.59 US$115,732
2026-02-23 2026-02-23 PrS Proposed sale
2.8
Berry Lance A

Officer

Officer
4,981
37.59
US$187,223 		4,981 37.59 US$187,223
2026-02-23 2026-02-23 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
2,423
37.59
US$91,075 		2,423 37.59 US$91,075
2025-12-17 2025-12-15 PrS Proposed sale
3.4
Davis John E

Officer

Officer
5,000
45.11
US$225,554 		5,000 45.11 US$225,554
2025-12-17 2025-12-15 S Sale
3.4
Davis John E

Chief Commercial Officer

Officer
5,000 -2.5%
45.11
US$225,550 		5,000 -2.5% 45.11 US$225,550
2025-12-09 2025-12-08 S Sale
3.5
Horton Amy

VP, Chief Accounting Officer

Officer
4,572 -3.4%
44.42
US$203,084 		4,572 -3.4% 44.42 US$203,084
2025-12-08 2025-12-08 PrS Proposed sale
3.5
Horton Amy

Officer

Officer
4,572
44.42
US$203,081 		4,572 44.42 US$203,081
2025-12-04 2025-12-03 PlS Planned sale
3.5
Mackin James P

President & CEO

Officer
30,921 -3.7%
45.46
US$1,405,700 		30,921 -3.7% 45.46 US$1,405,700
2025-12-04 2025-12-03 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
5,267 -3.3%
45.30
US$238,595 		5,267 -3.3% 45.30 US$238,595
2025-12-04 2025-12-03 S Sale
3.5
Holloway Jean F

SVP, General Counsel

Officer
2,048 -1.3%
45.30
US$92,774 		2,048 -1.3% 45.30 US$92,774
2025-12-03 2025-12-03 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
30,921
45.46
US$1,405,695 		30,921 45.46 US$1,405,695
2025-12-03 2025-12-03 PrS Proposed sale
3.5
JEAN F HOLLOWAY

Officer

Officer
7,315
45.30
US$331,391 		7,315 45.30 US$331,391
2025-12-03 2025-12-02 PlS Planned sale
3.5
Mackin James P

President & CEO

Officer
30,921 -3.7%
45.56
US$1,408,730 		30,921 -3.7% 45.56 US$1,408,730
2025-12-02 2025-12-02 PrS Proposed sale
3.5
Mackin James P

Officer; Director

Executive Director
30,921
46.27
US$1,430,715 		30,921 46.27 US$1,430,715
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
8,370 -15.8%
45.35
US$379,538 		8,370 -15.8% 45.35 US$379,538
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
18,705 -26.0%
44.91
US$840,042 		18,705 -26.0% 44.91 US$840,042
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
5,715 -11.3%
45.35
US$259,152 		5,715 -11.3% 45.35 US$259,152
2025-11-24 2025-11-21 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
14,586 -22.4%
44.92
US$655,189 		14,586 -22.4% 44.92 US$655,189
2025-11-21 2025-11-21 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
47,376
45.04
US$2,133,936 		47,376 45.04 US$2,133,936
2025-11-24 2025-11-20 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
1,355 -2.9%
44.28
US$59,997 		1,355 -2.9% 44.28 US$59,997
2025-11-24 2025-11-20 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
2,033 -4.3%
44.32
US$90,092 		2,033 -4.3% 44.32 US$90,092
2025-11-24 2025-11-20 S Sale
3.4
Stanton Marshall S.

SVP, Clinical & MD Affair

Officer
11,888 -21.0%
44.14
US$524,736 		11,888 -21.0% 44.14 US$524,736
2025-11-20 2025-11-20 PrS Proposed sale
3.4
Stanton Marshall S.

Officer

Officer
15,276
44.18
US$674,833 		15,276 44.18 US$674,833
2025-11-19 2025-11-18 S Sale
2.3
Hoff Elizabeth A
Non-Executive Director
4,200 -13.4%
45.10
US$189,412 		4,200 -13.4% 45.10 US$189,412
Explore more

More insider trading research around Artivion Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America